Article contributed and authored by: Dr. Alex Young, NHS surgeon and founder of Virti It’s estimated by the World Health Organisation (WHO) that there are more than 2 million different kinds of medical devices in the global market, ranging from surgical instruments to wound care apparatus and diagnostic software. Without them, modern medical practice as we know it would be … [Read more...]
How to use digital platforms to engage with your customers
Article contributed to PharmaLeaders by Rachel Murray, Head of Partnerships, Fountain Partnership The last year has seen the Pharma industry propelled into the digital world in order to deliver clear communication to healthcare professionals and customers. Traditionally reliant on face-to-face communication, including selling, the Covid-19 pandemic has accelerated online … [Read more...]
How Natural Language Processing Unlocks the Full Healthcare and Patient Journey
Contributed to PharmaLeaders by Authors: By Ana Bargo, M.S.; Jeannine Cain, MSHI, RHIA, CPHI; Shannon Fee, B.A.; Mark Yap, FNP-C In 2016, a major transformation occurred in how we evaluate clinical data for real-world effectiveness. The FDA signed into law the 21st Century Cures Act, which impacted the Real-World Evidence Program in the U.S. It signaled a paradigm shift in … [Read more...]
Going Virtual
Contributing Author: Chris Mycek, President at WORLEY Pivoting to virtual….Google it, you’ll find it’s a common current theme that will have enduring repercussions on how things get done. Zoom is a new household word, and now a verb as well. Amazon Prime, Netflix, FedEx, are all booming. Nesting at home, with new entertainment centers, pools, and other home luxuries are also … [Read more...]
COVID-19 Accelerates Digital Transformation in Life Sciences
Author: Andy Fuchs, VP of Commercial Strategy, Veeva Systems Public safety is the world’s singular goal as mandatory quarantines, shelter-in-place orders, travel restrictions, and mandatory work-from-home policies go into effect to curb the spread of COVID-19. In response, many biopharmaceutical companies are shifting how they work: Amarin withdrew part of its field force, … [Read more...]